Therapeutic Use License

If you are considering solutions/technologies for medical applications for use in regenerative medicine, cell therapy and transplantation, human and animal treatment, disease prevention and diagnosis, please see here.

Standard Financial Terms

Non-Exclusive worldwide license for each differentiated cell types
(Patents to be licensed: AJ001, AJ002, AJ005, AJ006, AJ018 and AJ066)
Fees and RoyaltiesSSE *1Non-SSE
Upfront fee US$13,000 US$60,000
Annual maintenance fee
(until NDA approval)
US$12,000 US$25,000
Milestone payments on first IND applications in each of 3 areas *2 (in total of 3 areas)
US$41,000
(in total of 3 areas)
US$130,000
Milestone payments on first NDA
applications in each of 3 areas *2
(in total of 3 areas)
US$250,000
(in total of 3 areas)
US$295,000
Milestone payment on
achievement of sales total
US$100M
US$400,000
Milestone payment on
achievement of sales total
US$500M
US$700,000
Running royalties 1.5% of sales of final products
Annual minimum royalties
(after NDA approval)
US$20,000 US$25,000
Fees and RoyaltiesSSE *1
Upfront fee US$13,000
Annual maintenance fee
(until NDA approval)
US$12,000
Milestone payments on first IND applications in each of 3 areas *2 (in total of 3 areas)
US$41,000
Milestone payments on first NDA
applications in each of 3 areas *2
(in total of 3 areas)
US$250,000
Milestone payment on achievement of sales total
US$100M
US$400,000
Milestone payment on achievement of sales total
US$500M
US$700,000
Running royalties 1.5% of sales of final products
Annual minimum royalties
(after NDA approval)
US$20,000
Fees and RoyaltiesNon-SSE
Upfront fee US$60,000
Annual maintenance fee
(until NDA approval)
US$25,000
Milestone payments on first IND applications in each of 3 areas *2 (in total of 3 areas)
US$130,000
Milestone payments on first NDA
applications in each of 3 areas *2
(in total of 3 areas)
US$295,000
Milestone payment on achievement of sales total
US$100M
US$400,000
Milestone payment on achievement of sales total
US$500M
US$700,000
Running royalties 1.5% of sales of final products
Annual minimum royalties
(after NDA approval)
US$25,000

∗1 A Small and Startup Entity (SSE) means an entity which (i) has been within 10 years from its foundation, (ii) employs 50 or fewer people, and (iii) has received US$20M or less in total as financial resources.
∗2 3 areas mean North America, Europe and the rest of the world.

Different conditions depending on cell types, etc. Please contact us for more information.

Standard Conditions for Payment